LexAurum Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $332K | Buy |
1,790
+154
| +9% | +$28.6K | 0.05% | 256 |
|
|
2025
Q1 | $343K | Sell |
1,636
-73
| -4% | -$15.3K | 0.07% | 242 |
|
|
2024
Q4 | $304K | Buy |
1,709
+549
| +47% | +$97.6K | 0.06% | 261 |
|
|
2024
Q3 | $229K | Buy |
+1,160
| New | +$229K | 0.05% | 278 |
|
|
2024
Q2 | – | Sell |
-1,152
| Closed | -$210K | – | 300 |
|
|
2024
Q1 | $210K | Buy |
+1,152
| New | +$210K | 0.05% | 275 |
|
|
2021
Q4 | – | Sell |
-7,735
| Closed | -$834K | – | 251 |
|
|
2021
Q3 | $834K | Buy |
7,735
+138
| +2% | +$14.9K | 0.25% | 98 |
|
|
2021
Q2 | $856K | Buy |
7,597
+440
| +6% | +$49.6K | 0.25% | 97 |
|
|
2021
Q1 | $775K | Buy |
7,157
+196
| +3% | +$21.2K | 0.26% | 89 |
|
|
2020
Q4 | $746K | Buy |
6,961
+2,237
| +47% | +$240K | 0.27% | 92 |
|
|
2020
Q3 | $414K | Buy |
4,724
+691
| +17% | +$60.6K | 0.17% | 122 |
|
|
2020
Q2 | $396K | Buy |
4,033
+552
| +16% | +$54.2K | 0.22% | 102 |
|
|
2020
Q1 | $265K | Buy |
+3,481
| New | +$265K | 0.18% | 125 |
|